Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis

Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy. In its first gene therapy test, it completely cured human cystic fibrosis lung tissue in culture.

Read the whole article on Physorg

More from Physorg